Pfizer

Ukraine has been actively receiving and distributing Pfizer-BioNTech’s Comirnaty COVID-19 vaccine, with multiple shipments having arrived since early this year. Recent news highlights the continued support from the United States, providing nearly a million more doses to help bolster the national vaccination campaign. Further, Ukraine's health ministry has adapted to using the Pfizer vaccine at various mass vaccination centers across the country to accelerate the inoculation process.

Notably, recent deliveries have included significant batches like the roughly 66,000 doses delivered last month, and more are expected as part of the global COVAX Facility in the upcoming days. The commitment by the Ukrainian government is underscored by an increased order, now totaling 20 million doses of the Pfizer vaccine, showcasing significant steps towards reaching a broader immunity.

Reviews and reports have consistently underscored the vaccine's effectiveness, pinned at approximately 98%, proving its crucial role in fighting the pandemic within the country. Such developments reflect a proactive approach in Ukraine's health responses and a robust partnership with international bodies and countries like the United States and China.